Rationale and design of a prospective, observational, multicentre study on the safety and efficacy of apixaban for the prevention of thromboembolism in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study.
Anastasios KartasIoannis DoundoulakisDespoina NtiloudiAthanasios KoutsakisDiamantis KosmidisGeorgios RampidisSotiria ApostolopoulouAlexandra FrogoudakiAfrodite TzifaDimosthenis AvramidisOlga NtzoyvaraSotiria LioriTereza MousiamaSophia Anastasia MouratoglouHaralambos KarvounisGeorge GiannakoulasPublished in: BMJ open (2020)
NCT03854149; Pre-results.